Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONTRIBUTE: Budesonide MMX add-on in UC
NCT01532648Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Jan 2012
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 11
01
Overview
A Phase 3 trial of EPI-EE in ulcerative colitis (UC), sponsored by Valeant Pharmaceuticals. Started Jan 2012; status: completed.
02
Drugs
EPI-EE
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01532648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01532648.